Format

Send to

Choose Destination
Nat Med. 2019 Nov;25(11):1753-1760. doi: 10.1038/s41591-019-0627-8. Epub 2019 Nov 7.

Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease.

Author information

1
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK. jennifer.lees@glasgow.ac.uk.
2
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
3
Glasgow Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.

Abstract

Chronic kidney disease is common in the general population and associated with excess cardiovascular disease (CVD), but kidney function does not feature in current CVD risk-prediction models. We tested three formulae for estimated glomerular filtration rate (eGFR) to determine which was the most clinically informative for predicting CVD and mortality. Using data from 440,526 participants from UK Biobank, eGFR was calculated using serum creatinine, cystatin C (eGFRcys) and creatinine-cystatin C. Associations of each eGFR with CVD outcome and mortality were compared using Cox models and adjusting for atherosclerotic risk factors (per relevant risk scores), and the predictive utility was determined by the C-statistic and categorical net reclassification index. We show that eGFRcys is most strongly associated with CVD and mortality, and, along with albuminuria, adds predictive discrimination to current CVD risk scores, whilst traditional creatinine-based measures are weakly associated with risk. Clinicians should consider measuring eGFRcys as part of cardiovascular risk assessment.

PMID:
31700174
PMCID:
PMC6858876
[Available on 2020-05-07]
DOI:
10.1038/s41591-019-0627-8

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center